Current antibody discovery technologies are limited in terms of their efficacy, accessibility, and scalability. The AHEAD system addresses these limitations by presenting an accelerated evolution workflow for antibody engineering that combines autonomous gene diversification with protein display technology.
- Paul R. Sargunas
- Jamie B. Spangler